Bio

Ben Larkin practice encompasses all aspects of corporate work including M&A and restructuring. He particularly has in-depth experience in infrastructure-related transactions. Ben is recognized as a leader in his field and is described by The Legal 500 as "exceptional" and is applauded by Chambers UK for his superior knowledge of the infrastructure sector. He has led significant cross-border M&A and restructurings in the infrastructure, health care, telecom, pharmaceutical, and energy sectors. He acts for a wide variety of funds, investment banks, and corporations. Ben also has been featured in Chambers as a notable practitioner in the restructuring sector, where clients say that he "really knows the risks and opportunities that distressed businesses face," explaining that "his understanding and experience help him get his clients what they need." He is regarded as an expert in infrastructure-related restructurings; clients say "he is brilliant at subject matter, tactics and negotiation." Recent experience includes the disposal of Marken, a global pharmaceutical distributor to UBS, representing Veolia on the refinancing and restructuring of the Harkand shipping group, acting for a major international bank on the cross-border restructuring of NMC Healthcare, as well as acting for an international infrastructure fund in relation to transactions in the telecoms, energy, renewables, and transport sectors.